Literature DB >> 70588

beta-adrenergic agonist resistance in normal human airways.

S T Holgate, C J Baldwin, A E Tattersfield.   

Abstract

The response to a beta2-agonist (salbutamol) was assessed by measuring specific airways conductance (sGaw) in healthy volunteers following increasing doses of inhaled or intravenous salbutamol. Regular inhaled salbutamol in doses exceeding 200 microgram four times a day produced a progressive loss of airways responsiveness to both inhaled and intravenous salbutamol (beta-agonist resistance). In salbutamol-resistant subjects full bronchodilator sensitivity was restored 3-5 h after intravenous hydrocortisone.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70588     DOI: 10.1016/s0140-6736(77)90304-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  44 in total

Review 1.  Antagonism of long-acting beta2-adrenoceptor agonism.

Authors:  Brian J Lipworth
Journal:  Br J Clin Pharmacol       Date:  2002-09       Impact factor: 4.335

2.  Ipratropium bromide (Sch 1000) monohydrate aerosol: bronchodilator effect of three dose levels in asthmatics.

Authors:  R E Ruffin; M T Newhouse
Journal:  Lung       Date:  1978       Impact factor: 2.584

3.  A method for bioassay of potency and effectiveness of inhaled bronchodilators in normal subjects.

Authors:  R W Foster; G K Atanga; J R Carpenter; D E Evans; K Rakshi; R C Small
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

4.  Current issues with beta2-adrenoceptor agonists: historical background.

Authors:  Anne E Tattersfield
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

Review 5.  Interactions between corticosteroids and beta2-agonists.

Authors:  Robert J Hancox
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

6.  Beta-adrenoceptor responses to inhaled salbutamol in normal subjects.

Authors:  B J Lipworth; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

7.  Effect of nedocromil sodium on the beta-adrenergic response of human polymorphonuclear leucocytes.

Authors:  W W Busse; B Randlev; M Arbabian; A Ruoho
Journal:  Drugs       Date:  1989       Impact factor: 9.546

8.  Changes in methacholine induced bronchoconstriction with the long acting beta 2 agonist salmeterol in mild to moderate asthmatic patients.

Authors:  H Booth; K Fishwick; R Harkawat; G Devereux; D J Hendrick; E H Walters
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

9.  Modification by betamethasone of the effects of bronchodilator drugs on cholinergic bronchoconstriction in rats.

Authors:  M J Mattila; R O Salonen
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

Review 10.  Benefit-risk assessment of long-acting beta2-agonists in asthma.

Authors:  Catherine M Jackson; Brian Lipworth
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.